WATSON 3700 (Ropinirole Hydrochloride Extended-Release 6 mg)
Pill with imprint WATSON 3700 is White, Elliptical / Oval and has been identified as Ropinirole Hydrochloride Extended-Release 6 mg. It is supplied by Watson Laboratories, Inc..
Ropinirole is used in the treatment of restless legs syndrome; periodic limb movement disorder; parkinson's disease; tardive dyskinesia and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Ropinirole 6 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for WATSON 3700
Ropinirole Hydrochloride Extended-Release
- Imprint:
- WATSON 3700
- Strength:
- 6 mg
- Color:
- White
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Drug Class:
- Dopaminergic antiparkinsonism agents
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Watson Laboratories, Inc.
- Inactive Ingredients:
- hypromelloses
mannitol
glyceryl dibehenate
lactose monohydrate
hydrogenated castor oil
povidone
sodium lauryl sulfate
magnesium silicate
magnesium stearate
silicon dioxide
triethyl citrate
titanium dioxide
polydextrose
triacetin
polyethylene glycol 8000
vinyl acetate
Note: Inactive ingredients may vary.
More about ropinirole
- Ropinirole Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Patient Tips
- Drug Images
- Drug Interactions
- Compare Alternatives
- Support Group
- Pricing & Coupons
- En Español
- 241 Reviews
- Drug class: dopaminergic antiparkinsonism agents
- FDA Alerts (1)
Consumer resources
Other brands: Requip, Requip XL
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
